Form 4: Amneal Pharmaceuticals Director Gautam Patel Sells $139,454 in Class A Common Stock

Director Gautam Patel sold 17,410 shares of Amneal Pharmaceuticals Class A Common Stock on January 2, 2025, at an average price of $8.01 per share.

Summary

• On January 2, 2025, Gautam Patel, a director of Amneal Pharmaceuticals, sold 17,410 shares of Class A Common Stock.
• The sale was executed at a weighted average price of $8.01 per share, with individual prices ranging from $8.00 to $8.06.
• The total value of the shares sold is approximately $139,454.
• Following the transaction, Patel directly owns 2,031,476 shares of Amneal Pharmaceuticals Class A Common Stock.
• The sale was conducted under a pre-arranged 10b5-1 trading plan adopted on August 15, 2024.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the transaction appears to be part of a pre-planned trading strategy and doesn't necessarily indicate a change in the director's confidence in the company.

Industry Context

Sales by company directors are a normal part of corporate governance. It is important to note that the sale was executed under a pre-arranged 10b5-1 trading plan, which allows corporate insiders to sell shares at predetermined times and prices to avoid accusations of insider trading.

Stakeholder Impact

• The sale of shares by a director could have a minor impact on shareholder sentiment, but the pre-arranged nature of the sale mitigates potential concerns.

Key Dates